早期支气管癌术前18F-FDG PET各种PET指标对无进展生存和总生存的预后价值分析:糖酵解显著增高是预测因素
研究纳入133例I-II期非小细胞肺癌切除术前患者,评估基于体积和背景活性的PET指标对无进展生存和总生存的预后价值。生存树分析中,背景减除病灶活性(BSL)大于6,852(P=0.017)被选为分割点,将13例归为高危组;去除BSL后,42%总病灶糖酵解(TLG42%)大于4,204(P=0.023)被选为分割点。结论认为基于体积的PET指标与PFS和OS相关,可用于I-II期NSCLC风险评估,但结果需在新患者数据中验证。
要点
- BSL大于6,852(P=0.017)被选为生存树分割点,将13例归为高危组。
- 去除BSL后,TLG42%大于4,204(P=0.023)被选为分割点。
- 所有对数转换PET指标间Pearson相关系数为0.703至0.962。
核心结论
- 基于体积的PET指标与PFS和OS相关,可用于I-II期NSCLC风险评估。
- 本研究中不同PET指标高度相关,因此预测PFS或OS无显著差异并不意外。
- 总体而言,体积大且代谢活跃的肿瘤应视为高风险,切除后可能需要进一步治疗。
- 由于所有分析步骤均使用同一数据,这些结果应在新患者数据中验证。
研究设计与样本
- 研究纳入133例患者,于2003年1月至2010年12月间术前接受充分的18F-FDG PET/CT扫描。
- 评估基于体积的PET定量指标(包括不同阈值的代谢肿瘤体积和总病灶糖酵解)及基于背景活性的PET指标(背景减除病灶活性[BSL]和背景减除体积)。
- 使用生存树分析区分高、低风险患者并选择最重要的预后标志物,采用Akaike信息准则比较2个单变量模型。
主要发现
- 研究期间,36例患者死于NSCLC,26例死于其他原因;随访结束时70例存活,其中67例无病。
- 所有对数转换PET指标呈强线性关联,Pearson相关系数在0.703至0.962之间。
- 多重检验校正后,生存树分析中仅1个预后标志物贡献显著分割点。
- 在包括7个PET指标在内的10个潜在预测因子中,BSL大于6,852(P=0.017)被选为分割点,将13例患者归为高危组。
- 若从预测因子集中去除BSL,则42%总病灶糖酵解(TLG42%)大于4,204(P=0.023)被选为分割点。
关键数值与推荐
- BSL大于6,852(P=0.017)被选为生存树分割点,将13例患者归为高危组。
- 去除BSL后,TLG42%大于4,204(P=0.023)被选为分割点。
- 所有对数转换PET指标间Pearson相关系数在0.703至0.962之间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 由于所有分析步骤均使用同一数据,这些结果应在新患者数据中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this study was to assess various volume-based PET quantification metrics, including metabolic tumor volume and total lesion glycolysis (TLG) with different thresholds, as well as background activity-based PET metrics (background-subtracted lesion activity [BSL] and background-subtracted volume) as prognostic markers for progression-free and overall survival (PFS and OS, respectively) in early-stage I and II non-small cell lung cancer (NSCLC) after resection. Methods: Patients (n = 133) underwent an adequate 18F-FDG PET/CT scan before surgery between January 2003 and December 2010. All PET activity metrics showed a skewed distribution and were log-transformed before calculation of the Pearson correlation coefficients. Survival tree analysis was used to discriminate between high- and low-risk patients and to select the most important prognostic markers. The Akaike information criterion was used to compare 2 univariate models. Results: Within the study time, 36 patients died from NSCLC and 26 patients from other causes. At the end of follow-up, 70 patients were alive, with 67 patients being free of disease. All log-transformed PET metrics showed a strong linear association, with a Pearson correlation coefficient between 0.703 and 0.962. After multiple testing corrections, only 1 prognostic marker contributed a significant split point in the survival tree analysis. Of 10 potential predictors including 7 PET metrics, a BSL greater than 6,852 (P = 0.017) was chosen as split point, assigning 13 patients into a high-risk group. If BSL was removed from the set of predictors, a 42% TLG (TLG42%) of greater than 4,204 (P = 0.023) was chosen as split point. When a dichotomized BSL or TLG42% variable was used for a univariate Cox model, the Akaike information criterion difference of both models was smaller than 2; therefore, the data do not provide evidence that 1 of the 2 prognostic factors is superior. Conclusion: Volume-based PET metrics correlate with PFS and OS and could be used for risk assessment in stage I-II NSCLC. The different PET metrics assessed in this study showed a high correlation; therefore, it is not surprising that there was no significant difference to predict PFS or OS within this study. Overall, patients with large and metabolically active tumors should be considered high risk and might need further treatment after resection. Because all analysis steps were done with the same data, these results should be validated on new patient data.
引用
- Steiger S, Arvanitakis M, Sick B, et al. Analysis of Prognostic Values of Various PET Metrics in Preoperative 18F-FDG PET for Early-Stage Bronchial Carcinoma for Progression-Free and Overall Survival: Significantly Increased Glycolysis Is a Predictive Factor. J Nucl Med. 2017. PMID: 28490471. doi:10.2967/jnumed.117.189894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。